Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Van Cutsem, Eric" or (type any "bookEditor journalEditor issueEditor" and editor="Van Cut...

Add to list
- Conference Paper
- C3
- open access
KEYNOTE-B79 phase 1b trial to evaluate the allogeneic CAR T-cells CYAD-101 and pembrolizumab in refractory metastatic colorectal cancer patients

Richard D. Kim, Hans Prenen, Sylvie Rottey (UGent) , Dae Won Kim, Anne Flament, Frederic Lehmann and Eric Van Cutsem

(2022) JOURNAL OF CLINICAL ONCOLOGY. In Journal of Clinical Oncology 40(4, supplement).
Add to list
- Journal Article
- A1
- open access
Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Ahmad Awada, Thierry Berghmans, Paul M. Clement, Kristof Cuppens, Bram De Wilde (UGent) , Jean-Pascal Machiels, Patrick Pauwels, Marc Peeters, Sylvie Rottey (UGent) and Eric Van Cutsem

(2022) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 169.
Add to list
- Journal Article
- A1
- open access
Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer

Ronan J. Kelly, Jaffer A. Ajani, Jaroslaw Kuzdzal, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Mendez, Josephine Feliciano, Satoru Motoyama, Astrid Lievre, et al.

(2021) NEW ENGLAND JOURNAL OF MEDICINE. 384(13). p.1191-1203
Add to list
- Journal Article
- A1
- open access
Chimeric antigen receptor-T cells for targeting solid tumors : current challenges and existing strategies

Lorraine Springuel, Caroline Lonez, Bertrand Alexandre, Eric Van Cutsem, Jean-Pascal H. Machiels, Marc Van Den Eynde, Hans Prenen, Alain Hendlisz, Leila Shaza, Javier Carrasco, et al.

(2019) BIODRUGS. 33(5). p.515-537
Add to list
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer

Eric Van Cutsem, Robert J Mayer, Stéphanie Laurent (UGent) , Robert Winkler, Cristina Grávalos, Manuel Benavides, Federico Longo-Munoz, Fabienne Portales, Fortunato Ciardiello, Salvatore Siena, et al.

(2018) EUROPEAN JOURNAL OF CANCER. 90. p.63-72
Add to list
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology

Ivan Borbath, Antonio Ceratti, Chris Verslype, Anne Demols, Thierry Delaunois, Stéphanie Laurent (UGent) , Anne Deleporte, Peter Vergauwe, A Van Maanen, Christine Sempoux, et al.

(2013) ANNALS OF ONCOLOGY. 24(11). p.2824-2829
Add to list
The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study

Daphne Hompes, André D'Hoore, Eric Van Cutsem, Steffen Fieuws, Wim Ceelen (UGent) , Marc Peeters (UGent) , Kurt Van der Speeten, Claude Bertrand, Hugues Legendre and Joseph Kerger

(2012) ANNALS OF SURGICAL ONCOLOGY. 19(7). p.2186-2194
Add to list
Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer

Uday Bharat Patel, Gina Brown, Harm Rutten, Nicholas West, David Sebag-Montefiore, Robert Glynne-Jones, Eric Rullier, Marc Peeters (UGent) , Eric Van Cutsem, Sergio Ricci, et al.

(2012) ANNALS OF SURGICAL ONCOLOGY. 19(9). p.2842-2852
Add to list
Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study

Eric Van Cutsem, Sabine Tejpar, Dirk Vanbeckevoort, Marc Peeters (UGent) , Yves Humblet, Hans Gelderblom, Jan B Vermorken, Frederic Viret, Bengt Glimelius, Elisa Gallerani, et al.

(2012) JOURNAL OF CLINICAL ONCOLOGY. 30(23). p.2861-2868
Add to list
FAPA Familial Adenomatous Polyposis Association: the Belgian polyposis registry

Alex Kartheuser, Stéphanie Laurent (UGent) , Denis Franchimont and Eric Van Cutsem

(2011) ACTA GASTRO-ENTEROLOGICA BELGICA. 74(3). p.413-414

Academic Bibliography

KEYNOTE-B79 phase 1b trial to evaluate the allogeneic CAR T-cells CYAD-101 and pembrolizumab in refractory metastatic colorectal cancer patients

Belgian expert consensus for tumor-agnostic treatment of NTRK gene fusion-driven solid tumors with larotrectinib

Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer

Chimeric antigen receptor-T cells for targeting solid tumors : current challenges and existing strategies

The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer

Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digstive Oncology

The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study

Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer

Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study

FAPA Familial Adenomatous Polyposis Association: the Belgian polyposis registry

Contents

Support

Contact